Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Levy

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulationG A Levy
Transplantation Proceedings|April 1, 1996
Neoral in liver transplantationG A Levy, D Grant
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
The major histocompatibility complex requirement for cellular collaboration in the murine lymphoid procoagulant response stimulated by bacterial lipopolysaccharideG A Levy, T S Edgington
Springer Seminars in Immunopathology|April 1, 1981
The immunopathogenesis of chronic HBV induced liver diseaseG A Levy, F V Chisari
Clinical Chemistry|May 1, 1992
Apparent duplicate publication was not intendedT W Wu, G A Levy
Critical Reviews in Clinical Laboratory Sciences|January 1, 1981
A proposed role for the immune system in the pathogenesis of hepatitis B virus induced liver diseaseG A Levy, F V Chisari
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1980
Lymphoid procoagulant activity and mitogenesis in the C3H/HeJ mouse: discordant response to lipopolysaccharide stimulationG A Levy, T S Edgington
The Journal of Experimental Medicine|May 1, 1980
Lymphocyte cooperation is required for amplification of macrophage procoagulant activityG A Levy, T S Edgington
The New England Journal of Medicine|July 28, 1994
Artificial liver support--pipe dream or reality?M S Cattral, G A Levy
Digestive Diseases and Sciences|June 1, 1991
Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary reportS B Sinclair, G A Levy
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulationG A Levy
Transplantation Proceedings|April 1, 1996
Neoral in liver transplantationG A Levy, D Grant
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
The major histocompatibility complex requirement for cellular collaboration in the murine lymphoid procoagulant response stimulated by bacterial lipopolysaccharideG A Levy, T S Edgington
Springer Seminars in Immunopathology|April 1, 1981
The immunopathogenesis of chronic HBV induced liver diseaseG A Levy, F V Chisari
Clinical Chemistry|May 1, 1992
Apparent duplicate publication was not intendedT W Wu, G A Levy
Critical Reviews in Clinical Laboratory Sciences|January 1, 1981
A proposed role for the immune system in the pathogenesis of hepatitis B virus induced liver diseaseG A Levy, F V Chisari
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1980
Lymphoid procoagulant activity and mitogenesis in the C3H/HeJ mouse: discordant response to lipopolysaccharide stimulationG A Levy, T S Edgington
The Journal of Experimental Medicine|May 1, 1980
Lymphocyte cooperation is required for amplification of macrophage procoagulant activityG A Levy, T S Edgington
The New England Journal of Medicine|July 28, 1994
Artificial liver support--pipe dream or reality?M S Cattral, G A Levy
Digestive Diseases and Sciences|June 1, 1991
Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary reportS B Sinclair, G A Levy
Pageof 16